Intellectual Property Cases
Cases 51 - 60 of 111
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG et al v. AUROBINDO PHARMA LIMITED et al
as 3:2019cv08840
Plaintiff: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG, BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant: AUROBINDO PHARMA USA, INC. and AUROBINDO PHARMA LIMITED
Cause Of Action: 15 U.S.C. § 1126
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. LUPIN ATLANTIS HOLDINGS SA et al
as 3:2018cv16708
Plaintiff: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. and BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Defendant: LUPIN LIMITED and LUPIN ATLANTIS HOLDINGS SA
Cause Of Action: 15 U.S.C. § 1126
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Aizant Drug Research Solutions Pvt. Ltd.
as 1:2018cv01783
Defendant: Aizant Drug Research Solutions Pvt. Ltd.
Plaintiff: Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Annora Pharma Private Limited et al
as 1:2018cv01786
Defendant: Hetero USA Inc. and Annora Pharma Private Limited
Plaintiff: Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Cipla Limited et al
as 1:2018cv01789
Defendant: Cipla USA, Inc. and Cipla Limited
Plaintiff: Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Prinston Pharmaceutical Inc.
as 1:2018cv01787
Defendant: Prinston Pharmaceutical Inc., Solco Healthcare US, LLC and Zhejiang Huahai Pharmaceutical Co., Ltd.
Plaintiff: Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. InvaGen Pharmaceuticals, Inc.
as 1:2018cv01788
Plaintiff: Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Defendant: InvaGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. MSN Laboratories Private Ltd. et al
as 1:2018cv01785
Defendant: MSN Pharmaceuticals Inc. and MSN Laboratories Private Ltd.
Plaintiff: Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Dr. Reddy's Laboratories, Ltd. et al
as 1:2018cv01779
Defendant: Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Plaintiff: Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2018cv01763
Defendant: Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited
Plaintiff: Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?